Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

(2021) Noa Dagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

BNT162b2 mRNA Covid-19 vaccine effectiveness in the prevention of SARS-CoV-2 infection: a preliminary report

(2021) Francesco Paolo Bianchi et al.   JOURNAL OF INFECTIOUS DISEASES

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

(2021) Eleftheria Vasileiou et al.   LANCET

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

(2021) Eric J Haas et al.   LANCET

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study

(2021) Victoria Jane Hall et al.   LANCET

COVID-19 dynamics after a national immunization program in Israel

(2021) Hagai Rossman et al.   NATURE MEDICINE

Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center

(2021) William Daniel et al.   NEW ENGLAND JOURNAL OF MEDICINE

County-Level COVID-19 Vaccination Coverage and Social Vulnerability — United States, December 14, 2020–March 1, 2021

(2021) Michelle M. Hughes et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021

(2021) Tamara Pilishvili et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

(2021) Mark W. Tenforde et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals

(2021) Oren Milman et al.   NATURE MEDICINE

Decreases in COVID-19 Cases, Emergency Department Visits, Hospital Admissions, and Deaths Among Older Adults Following the Introduction of COVID-19 Vaccine — United States, September 6, 2020–May 1, 2021

(2021) Athalia Christie et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020

(2020) et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020

(2020) Kathleen Dooling et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020

(2020) Kathleen Dooling et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT